Thymosin Alpha-1 Dosage: A Complete 2026 Guide

In studies, thymosin alpha-1 is most often dosed at 1.6 mg by subcutaneous injection twice a week, spaced 3 to 4 days apart. That is the dose used in the branded version, Zadaxin, in trials that ran about 24 to 26 weeks. Some clinics use a smaller daily dose, around 300 to 500 mcg. pru does not offer thymosin alpha-1 today, so this guide explains the numbers, then points you to the longevity peptides pru does offer.

Thymosin alpha-1 dosage at a glance

The most-studied thymosin alpha-1 dose is 1.6 mg, given as a subcutaneous injection twice a week. That single number comes from the branded drug thymalfasin, sold abroad as Zadaxin, and it anchors most protocols you will read about.

Two other patterns show up in clinic and educational protocols: a small daily dose of about 300 to 500 mcg, and a short higher-dose block of 1.6 to 3.2 mg daily for a few days when faster immune activation is the goal. Reported single doses across sources range from 0.8 mg to 6.4 mg.

The standard protocols, explained

The 1.6 mg twice-weekly protocol is the backbone. It came out of Phase III trials of thymalfasin in chronic hepatitis B, where 1.6 mg was injected under the skin twice a week for roughly 24 to 26 weeks. That is the closest thing thymosin alpha-1 has to a pharmaceutical dose.

Daily microdosing is the second common pattern. Here the dose is much smaller, about 300 to 500 mcg once a day, often started low and raised slowly. The idea is a steady, gentle signal rather than a twice-weekly pulse.

• Standard: 1.6 mg subcutaneous, twice weekly, spaced 3 to 4 days apart.
• Microdose: 300 to 500 mcg once daily, titrated up gradually.
• Short block: 1.6 to 3.2 mg daily for 3 to 7 days, then stop or step down.
• Cycle length in studies ran from about 12 to 52 weeks depending on the question being asked.

How thymosin alpha-1 works, in plain terms

Thymosin alpha-1 is a small peptide the body makes in the thymus, the gland that trains immune cells. It is studied mainly for immune modulation, meaning it is thought to help the immune system respond in a more balanced way rather than simply pushing it up or down.

Researchers describe it acting as a signal to T-cells and dendritic cells, the cells that recognize threats. That signaling is one reason interest in the peptide has grown among people focused on healthy aging, since immune balance tends to shift with age.

Dosing schedule and timing

Timing matters less for thymosin alpha-1 than for many peptides, because the effect builds over weeks, not hours. Its level in the blood peaks about 1 to 2 hours after injection and clears with a half-life of only 2 to 3 hours, yet the immune-cell changes it is studied for tend to develop over 4 to 8 weeks of steady dosing.

On the twice-weekly plan, doses are spaced 3 to 4 days apart, for example Monday and Thursday. On a daily plan, a consistent time each day is the main aim. Injection sites are rotated between the abdomen, thigh, and upper arm to keep the skin comfortable.

Reconstitution and storage

Thymosin alpha-1 ships as a freeze-dried powder that must be mixed before use. In a pharmacy-grade setting, a clinician or pharmacist mixes it with bacteriostatic water, adding the liquid slowly down the side of the vial and swirling gently until clear. It is never shaken, since that can damage the peptide.

• Powder: store at 2 to 8 degrees C, protected from light; do not freeze. Sealed vials stay stable for up to 24 months.
• After mixing: keep refrigerated at 2 to 8 degrees C and use within about 30 days.
• Never freeze the mixed solution; freeze-thaw cycles break down the peptide.
• The finished solution should look clear and colorless.

Side effects and safety

Thymosin alpha-1, and its synthetic form thymalfasin, have a well-studied safety record and are generally well tolerated in trials. The most common issues are minor and local: redness, mild irritation, or discomfort at the injection site.

Some people report short-lived fatigue in the days after the first few injections, which is often described as consistent with immune activation. Mild flu-like feelings have been noted infrequently early in a cycle. Anyone with an autoimmune condition, or who is pregnant or breastfeeding, should talk to a clinician before considering any immune peptide.

• Most common: injection-site redness or irritation.
• Occasional: transient fatigue in the first days.
• Infrequent: mild flu-like feelings early in a cycle.
• Always screen with a clinician if you have an autoimmune history.

Who looks into thymosin alpha-1

Interest in thymosin alpha-1 clusters among active adults roughly 45 to 65 who are focused on energy, resilience, and healthy aging. Immune balance is a natural entry point into the wider longevity conversation, which is where peptides like NAD+ and glutathione also live.

The US legal status you should know

Here is the part that changes the whole dosage question in the United States. Thymalfasin is approved as a medicine in more than 35 countries, but it is not FDA-approved in the US. In 2023 the FDA placed thymosin alpha-1 into Category 2 of its interim 503A list, which meant compounding pharmacies could not legally use it, and it moved to formal advisory review after that.

So today in the US, thymosin alpha-1 is not available through a legitimate prescriber and pharmacy path. What is sold online is grey-market or research-grade material, labeled not for human use, with no clinician and no licensed pharmacy standing behind it. That is the real risk, not the molecule itself.

How pru handles thymosin alpha-1

pru does not offer thymosin alpha-1 today, because there is no compliant prescriber-and-pharmacy path for it in the US. pru is built the opposite way from grey-market vials: a licensed physician confirms fit, and an FDA-regulated 503A compounding pharmacy fills what is prescribed. If a lawful pathway opens for thymosin alpha-1, pru would offer it that same way, done right.

For the immune and healthy-aging goals that draw people to thymosin alpha-1, pru's live longevity options are NAD+ and glutathione. NAD+ is the cellular coenzyme itself, offered by injection and nasal, and is studied for energy and cellular support. Glutathione is a master antioxidant offered by injection. Both are prescribed by a physician and filled by a 503A pharmacy.

Membership runs about 50 dollars a month, and the peptides themselves are sold separately at cost, itemized with no markup. You can compare the live options in the cellular health catalog, or read the NAD+ and glutathione pages directly. Getting curious about immune balance and healthy aging is a smart, proactive instinct, and pru exists to make that informed choice the accessible one, with licensed physicians, pharmacy-grade medicine, and at-cost pricing behind it. Take the next step whenever you are ready.

Related reading

Keep exploring the immune and longevity peptide landscape with these guides.

• Thymosin alpha-1 benefits
• Best peptides for longevity
• Peptides for telomere support
• NAD+ benefits
• NAD+ for energy and brain fog
• Glutathione benefits

Or browse the full cellular health catalog to see what pru offers today.

Common questions